Resilience and Modification of Brain Control Network Following November 13

NCT ID: NCT02810197

Last Updated: 2025-01-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

180 participants

Study Classification

INTERVENTIONAL

Study Start Date

2016-06-13

Study Completion Date

2025-12-08

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a multiwave longitudinal neuroimaging study in a cohort of direct survivors of 11/13 Paris terrorist attacks. Both structural and functional brain imaging data will be collected at 8-12 months, 3 years, and 6 years after trauma in exposed participants as well as in control non-exposed participants. This project will capitalize on recent evidence showing that healthy participants can prevent unwanted images from entering consciousness using inhibitory control and memory suppression techniques, disrupting traces of the memories in sensory areas of the brain, and weakening their vividness and later reentrance. This process is believed to be affected in Post-traumatic stress disorder (PTSD) which is characterized by anxiety and persistent intrusive memory of the traumatic event with highly distressing contents. This project will thus provide a unique opportunity to observe the online and structural dysfunctions of intrusion control network following a severe psychological trauma and how such process may contribute to recovery and psychopathological dynamics. In addition, the disruption of social cognition and emotional processing following PTSD will also be investigated in relation to disrupted inhibitory control functioning.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Post-Traumatic Stress Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Exposed group

Psychopathological assessment Neuropsychological assessment Functional magnetic resonance imaging (fMRI)

Group Type EXPERIMENTAL

Psychopathological assessment

Intervention Type BEHAVIORAL

Neuropsychological assessment

Intervention Type BEHAVIORAL

Functional magnetic resonance imaging (fMRI)

Intervention Type DEVICE

unexposed group

Psychopathological assessment Neuropsychological assessment Functional magnetic resonance imaging (fMRI)

Group Type EXPERIMENTAL

Psychopathological assessment

Intervention Type BEHAVIORAL

Neuropsychological assessment

Intervention Type BEHAVIORAL

Functional magnetic resonance imaging (fMRI)

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Psychopathological assessment

Intervention Type BEHAVIORAL

Neuropsychological assessment

Intervention Type BEHAVIORAL

Functional magnetic resonance imaging (fMRI)

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Participants between 18 and 55 years old.
* Present at the scene of the attacks the evening of 13 November 2015 or inhabitant of one of the neighbourhood affected by the attacks (exposed group), or persons were not in Paris on the evening of the attacks and not residing in Paris and its region (unexposed group).
* Affiliated to the French national health care system
* Have a good knowledge of the French language
* Right-handed
* Body mass less than or equal to 35kg/m2
* Signed written consent form

Exclusion Criteria

* Pregnancy or intent to get pregnant
* Person deprived of their liberty
* Person admitted to a health or social institution for purposes other than research
* Minor
* Person subjected to an exclusion period related to another protocol
* History of severe psychiatric disorders before the attacks : psychotic disorders, bipolar disorder, obsessive compulsive disorder and / or substance use disorders (excluding tobacco addiction)
* Use of medication that may interfere with cognitive or cerebral functioning
* Presence of visual or hearing troubles that may compromise participant's ability to participate in the study
* MRI Contraindications
Minimum Eligible Age

18 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Vincent de La Sayette, MD

Role: PRINCIPAL_INVESTIGATOR

University Hospital, Caen

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

GIP Cyceron

Caen, Calvados, France

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

France

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Pierre Gagnepain, PhD

Role: CONTACT

References

Explore related publications, articles, or registry entries linked to this study.

Coll SY, Eustache F, Doidy F, Fraisse F, Peschanski D, Dayan J, Gagnepain P, Laisney M. Avoidance behaviour generalizes to eye processing in posttraumatic stress disorder. Eur J Psychotraumatol. 2022 Apr 20;13(1):2044661. doi: 10.1080/20008198.2022.2044661. eCollection 2022.

Reference Type DERIVED
PMID: 35479300 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

C16-13

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Brain Injury and Cognitive Function
NCT05922748 RECRUITING NA
Brain, Emotions, and Mind-Wandering
NCT05345392 RECRUITING NA
Cognitive Adaptation
NCT03119909 UNKNOWN NA